Ulrich von Andrian

Ulrich von Andrian, MD, PhD is the Mallinckrodt Professor of Immunopathology at Harvard Medical School. His scientific research is focused on the regulation and function of immune cells in health and disease. To this end, his laboratory employs intravital microscopy techniques combined with other experimental approaches to study the migration, communication, differentiation, and function of immune cells in living animals.

In 1989, Dr. von Andrian joined the La Jolla Institute for Experimental Medicine and UCSD as a postdoctoral fellow working with Dr. Karl E. Arfors. His postdoctoral research involved the development of intravital microscopy techniques that led to the discovery of the multi-step leukocyte adhesion cascade in vivo. After a second postdoctoral fellowship in the laboratory of Dr. Eugene C. Butcher at Stanford University, Dr. von Andrian joined the faculty of Harvard Medical School in 1994. He was appointed to his current position in 2006. Dr. von Andrian is a scientific founder of Selecta Biosciences, Inc. and is a scientific advisor to various biotechnology companies, including Moderna.

Dr. von Andrian received his medical degree from the Ludwig Maximilian University in Munich, Germany, where he also conducted doctorate research on blood-brain barrier dysfunction following brain injury.